Zygotic expression of the BMP-4 gene in Xenopus embryos is regulated by an auto-regulatory loop. Since AP-1 is known as a mediator of auto-regulatory loops both in the case of the Drosophila dpp and the mammalian TGF-b genes, we have analysed the potential of Xenopus cJun (AP-1) as a mediator of BMP-4 expression during Xenopus development. RNA injection experiments revealed that both heteromeric cFos/c-Jun and homodimeric c-Jun/c-Jun strongly activate BMP-4 transcription, whereas BMP signaling was found to activate the Xenopus cJun gene only at a rather low extent. In addition, the lack of zygotic c-Jun transcripts until the end of gastrulation should exclude a role of AP-1 in the activation and the early expression of BMP-4 during gastrulation in vivo. However, at later stages of Xenopus development, we ®nd a spatial overlap of c-Jun and BMP-4 transcripts which suggests that AP-1 might serve as an additional activatory component for the autoregulation of BMP-4. Promoter/reporter and gel mobility shift assays demonstrate multiple responsive sites for AP-1 in the 5
Introduction
Bone morphogenetic protein 4 (BMP-4) is regarded as a key signal for dorsoventral patterning in vertebrate embryos (reviewed in Hogan, 1996; Graff, 1997) . The Xenopus BMP-4 gene is zygotically activated at the ventral side of late blastula/early gastrula stage embryos (Ko Èster et al., 1991; Fainsod et al., 1994) and its regulation is subject to an autoregulatory loop (Jones et al., 1992) . Early expression is regulated by the homeodomain protein Xvent-2 (Schuler- Metz et al., 2000) which, by itself, is a direct downstream target of BMP-4 signaling (Rastegar et al., 1999; Hata et al., 2000; Henningfeld et al., 2000) . On the other hand, results obtained from other species for different members of the TGF-b family suggest that additional factors may be involved as transcriptional regulators for the BMP-4 gene and may even participate in the auto-regulatory loop. For example, in the case of the Drosophila homologue decapentaplegic (dpp) expression in visceral mesoderm is regulated by ultrabithorax (ubx) which itself is upregulated by dpp (Hursh et al., 1993; Thu Èringer and Bienz, 1993) and, at dorsal closure, the dpp target Fos (DFos) co-operates with Jun (DJun) by regulating the expression of dpp (RiesgoEscovar and Hafen, 1997 ). An analogous auto-regulatory loop involving AP-1 (Activator Protein 1: c-Fos/c-Jun heterodimer or c-Jun homodimer) had already been described for the auto-induction of TGF-b (Kim et al., 1990) . Smad3/Smad4 and AP-1 complexes synergize in TGF-b induced transcriptional activation of the c-Jun promoter (Zhang et al., 1998; Wong et al., 1999; Liberati et al., 1999) and, vice versa, Jun and Fos promote expression of TGF-b.
Accumulating evidence suggests that a similar situation might also be anticipated for the vertebrate BMP-4 gene. Injection of BMP-4 RNA into Xenopus embryos led to an increase of AP-1 activity, whereas injection of the dominant negative BMP receptor RNA resulted in an inhibition of AP-1 . Thus it is evident that AP-1 is a downstream effector of BMP-4; however, this ®nding does not answer the questions, whether AP-1 components are transcriptionally regulated or activated at the protein level and, in turn, whether AP-1 can also upregulate BMP-4 transcription.
If AP-1 acts on the BMP-4 promoter, the corresponding target sites have to be shown to enhance transcriptional regulation. The organization and nucleotide sequence of the Xenopus BMP-4 gene have recently been reported (Metz et al., 1998; Kim et al., 1998a) . Injections of AP-1 strongly increased reporter activities driven by a 3.6 kb fragment of the 5
H¯a nking region (Kim et al., 1998a) . To investigate, whether these observations are relevant for the in vivo situation, we have analyzed by in situ whole-mount hybridization the transcription of the BMP-4 gene upon injection of AP-1 and, vice versa, transcription of the cJun gene upon injection of BMP-4. While ectopic expression of BMP-4 leads to a weak activation of c-Jun, both cJun/c-Fos and c-Jun strongly upregulate BMP-4. By injecting various deletion mutant/reporter constructs and by mobility shift assays we have mapped the regions within the upstream and intron sequences which contribute to transcriptional activation of the BMP-4 gene upon co-injection of c-Jun (AP-1). The results suggest a model, according to which c-Jun (AP-1) at later developmental stages might serve as an additional activator of BMP-4 gene transcription in vivo and might also function as a component of the autoregulatory loop. This model is consistent with the ®ndings that spatial expression patterns of BMP-4 and c-Jun show a partial overlap from the end of neurula stages until hatching.
Results

Sequence and expression pattern of Xenopus c-Jun
Since we have identi®ed AP-1 as an activator of BMP-4 gene transcription (see below), we switched from initially used mouse sequences to the corresponding Xenopus sequences. While sequence and developmental expression pattern of Xenopus c-Fos was already described (Kindy and Verma, 1990) , in case of Xenopus c-Jun only a 275 bp fragment encoding the C-terminal part of the protein had been characterized (Lazarus and Calcagnotto, 1994) . Using this PCR fragment as labeled probe we have isolated both pseudo-allelic cDNAs from a stage 30 Xenopus cDNA library. Derived protein sequences are shown in Fig. 1 . The high degree of evolutionary conservation, especially within the N-and C-terminal domains, the latter containing the basic DNA binding region and the leucine zipper, readily explains that no signi®cant differences were obtained when using murine or Xenopus c-Jun RNA in co-injection experiments as described below. Temporal expression of Xenopus c-Jun during early development was determined by RT-PCR using total RNA from embryos at different developmental stages (Nieuwkoop and Faber, 1975) . The gene is maternally transcribed and the pool of maternal transcripts is gradually diminished until the blastula or gastrula stage, respectively. Zygotic expression is ®rst detected during neurulation and transcripts persist until the end of embryogenesis. The spatial expression pattern of Xenopus c-Jun was analyzed by in situ whole-mount hybridization (Fig. 2B±F) . Weak staining was already observed in early cleavage stage embryos, thereby indicating the presence of maternal transcripts. While gastrula stage embryos are devoid of c-Jun transcripts, we observe zygotic expression in ventral and lateral regions but not in the dorsal midline at the late neurula stage. Interestingly, this and the subsequent patterns during organogenesis stages show a partial overlap to those of BMP-4 (Fainsod et al., 1994;  see Fig. 2G ), e.g. transcription in trunk neural crest, the otic vesicle, the eye and head mesenchyme. The temporal expression pattern of c-Jun also correlates to that of c-Fos, i.e. maternal transcripts are mostly diminished until the early gastrula stage and zygotic transcription starts during neurulation (Kindy and Verma, 1990) .
AP-1 activates BMP-4 expression and suppresses head formation
To investigate the role of AP-1 on BMP-4 gene transcription in vivo, the corresponding RNAs were injected into dorsal blastomeres of four-cell stage embryos which were subsequently analyzed for the presence of BMP-4 transcripts. Fig. 3A ,B demonstrates that AP-1 RNA injection (equal amounts of c-Jun and c-Fos RNA) expands the ventral and lateral expression of BMP-4 and leads to circumferential expression around the blastoporus. This ectopic BMP-4 expression is also observed upon injection of c-Jun RNA alone (Fig. 3C ). Vice versa, dorsal injection of either BMP-4 RNA or BMP-2 RNA leads to a weak but distinct increase of c-Jun expression at the dorsal side ( Fig.  3D ,E). In conclusion, AP-1 can be regarded as a potential activator of the BMP-4 gene and might participate in its auto-catalytic regulation.
Ectopic overexpression of the two mammalian components of AP-1 (c-Jun and c-Fos, but not alone) was reported to produce posteriorized embryos and to induce mesoderm formation in animal cap explants (Kim et al., 1998b) . In contrast, we here show that injection of 1.5 ng Xenopus cJun RNA alone into both dorsal blastomeres of four-cell stage embryos is also suf®cient to suppress head formation and to generate a posteriorized phenotype (Fig. 3F ). About 70% of injected embryos (two independent experiments with each 50 embryos and different RNA preparations; about 80% surviving) showed loss of anterior structures ranging from missing eyes to complete lack of head. This effect is dose dependent and the discrepancy to previously published results might be explained by the fact that former injections were performed with two-cell stage embryos; injection into dorsal blastomeres of four-cell stage embryos leads to a much higher protein concentration within derived tissues, such as dorsal mesoderm and neuroectoderm.
Upstream and intron AP-1 binding sites regulate the BMP-4 gene
Injections of promoter/reporter DNA constructs into Xenopus embryos have demonstrated that the Xenopus BMP-4 promoter is activated by several enhancers located within the 5
H¯a nking region and within the second intron (Metz et al., 1998) . We could further show that the homeodomain protein Xvent-2 plays an important role in the activation and early expression of the Xenopus BMP-4 gene by indirectly interacting with an enhancer in the proximal 5
H¯a nking region and, being even more effective, directly acting on an Xvent-2 target site located within intron 2 (Schuler- Metz et al., 2000) . The observation that c-Jun (AP-1) strongly upregulates BMP-4 gene transcription (Fig. 3 ) has prompted us to analyse the BMP-4 promoter for AP-1 target sites and for its ability to drive reporter gene expression upon co-injection with AP-1.
Computer aided inspection of the nucleotide sequence of the BMP-4 gene including 5 kbp upstream and 5 kbp downstream revealed seven putative AP-1 consensus binding sites (5 H -TGASTMA-3 H ; S: G or C, M: A or C), ®ve of them within the 5
H¯a nking region (24946, 24245, 23063, 2697, 2365) and two within the second intron (12044 and 12459) (see Fig. 4A ). While the longest mutant used did not contain the ®rst site, all other sites could be checked for reporter gene activation upon co-injection with AP-1 RNA. Initial co-injection experiments were performed with mouse c-Fos and c-Jun RNAs. Noteworthy, when using the Xenopus instead of the mouse sequence, no signi®cant difference in reporter gene activation was detected. Fig. 4B ,C demonstrates that both the upstream region as well as the second intron contribute to the AP-1 response. Setting the reporter activities as 100%, we observed a gradual loss of stimulation upon co-injection with AP-1, when individual AP-1 sites of the upstream region or the intron were removed. From these results we conclude that, in addition to Xvent-2, AP-1 is a potent stimulator of the BMP-4 gene by utilizing various upstream and intron binding sites. Thereby, AP-1 represents an additional transcription factor which could be involved in the regulation of BMP-4.
c-Jun protein interacts with multiple enhancers on the BMP-4 gene
To test whether the biological effects observed upon coinjection of deletion mutants with AP-1 RNA re¯ects direct binding of corresponding proteins to their target sequences we have performed gel retardation assays with c-Jun protein. Binding reactions performed with the c-Jun protein on all target sites tested (2697, 2365, 12044 and 12459) led to a mobility shift of the individual binding sites (Fig. 5) . Although the targets were shifted at varying extents due to selective af®nity of c-Jun to different binding sites (Bohmann et al., 1987 ), the results demonstrate that c-Jun has a capacity to bind each of these sites and that this property correlates with the biological response obtained in the reporter gene assays. H¯a nking region (B) and the second intron (C) contain putative target sites for AP-1. DNA (20 pg) of upstream (B) or intron/reporter fusion constructs (C) were injected into both blastomeres of two-cell stage embryos. Luciferase activity was measured, when uninjected control siblings had reached stage 12.5. Serial deletions of individual sites lead to a gradual loss of reporter activity when individual mutants were co-injected with 400 pg AP-1 RNA. Since absolute luciferase activities varied in separate experiments, results from co-injection experiments are given as relative values referring to DNA injections alone. The average values have been determined from at least three independent experiments.
BMP-4 activation by AP-1 is independent of Xvent-2 and may be due to c-Jun homodimers
Our further investigations asked whether heterodimeric AP-1 or homodimeric c-Jun activity interferes with Xvent-2 activity, or vice versa. While the results obtained with the 11951 mutant which contains only the AP-1 sites but no Xvent-2 site already imply an independent mode of action for both factors, we have investigated whether luciferase activities achieved for the complete intron mutant by AP-1 and Xvent-2 are additive or potentiating. Obtained values (Fig. 6A) do not argue for any potentiation, suggesting that these factors act independently. Furthermore, we have utilized the dominant negative Xvent-2 (P40) mutant (Onichtchouk et al., 1998) which is known to supress the intron 2 enhancer of the BMP-4 gene (Schuler- Metz et al., 2000) . The inhibition caused by Xvent-2 (P40) can be rescued by co-injection with AP-1. Fig. 6A shows reporter activities obtained after co-injections of the intron/reporter fusion with Xvent-2 (P40), AP-1 and combinations of these two factors. Moreover, neither Xvent-2 nor Xvent-2 (P40) in¯uence the 11951/12088 mutant which contains only the ®rst AP-1 site of the intron. Also, AP-1 stimulation of this mutant is not affected by co-injection of Xvent-2 or Xvent-2 (P40), respectively (Fig. 6A) . Thus, all results support the notion that Xvent-2 and AP-1 operate by independent activatory mechanisms.
Since the heterodimeric AP-1 complex contains c-Fos and c-Jun, but c-Jun is also known to form homodimers which bind to the AP-1 site, we have checked whether AP-1 activity can be mimicked by separate injections of anking region and the complete intron 2 as well as a mutant containing the intron alone are activated by 350 pg AP-1 or 350 pg c-Jun RNA, respectively, whereas 350 pg c-Fos RNA exhibits almost no effect. All injections were performed into both dorsal blastomeres of four-cell stage embryos which were harvested for measuring reporter gene activities when uninjected control siblings had reached stage 12.5. the two AP-1 components. Interestingly, for both an upstream/intron mutant as well as for the intron alone we observed that c-Jun injection is slightly more effective than AP-1, whereas c-Fos injection alone is rather ineffective (Fig. 6B ). This ®nding is consistent with the fact that cFos lacks DNA binding capacity on its own. The results demonstrate that c-Jun injection alone is able to mimic AP-1 activity suggesting that c-Jun homodimers are suf®-cient for BMP-4 gene activation.
Discussion
RNA injection experiments have shown that the Xenopus BMP-4 gene is activated by c-Jun (AP-1). Vice versa, c-Jun is activated by BMP-4, albeit at a lesser extent. With this limitation in mind, AP-1 might be regarded as an additional mediator of the auto-regulatory loop of BMP-4 expression. Activation of c-Jun by BMP-4 seems to be due to transcriptional activation (see Fig. 3E ), like previously observed for TGF-b induced activation (Pertovaara et al., 1989) , rather than to c-Jun N-terminal kinase mediated activation of the protein (Hocevar et al., 1999) . However, both alternatives are not exclusive, since c-Jun is also known to be regulated by an auto-regulatory loop. Whether the BMP signal is transduced via Smads or TAK1/TAB1, a MAPKKK and its activator (Shibuya et al., 1998) , remains to be elucidated. Involvement of AP-1 in ventral mesoderm formation has also been described within the context of the FGF/Xbra auto-regulatory loop. Ras/AP-1 being activated by FGF upregulate Xbra, which in turn serves as an activator for embryonic FGF Kim et al., 1998b; Latinkic et al., 1997) . Injection of AP-1 RNA leads to an posteriorized and ventralized phenotype. While we support the notion that AP-1 is much more effective, we have found that c-Jun RNA dorsally injected at higher concentrations also leads to ventralization. The ®nding of AP-1 as an activator of BMP-4 thus represents a link between these two auto-catalytic loops of growth factors (FGF and BMP) being essential in ventral mesoderm formation. These results also render a possible explanation for the observation that overexpression of AP-1 leads to a ventralized phenotype, because AP-1 activates BMP-4 which is known to induce the ventralization process (Dale et al., 1992; Jones et al., 1992) .
To localize enhancers on the BMP-4 promoter which interact with factors being involved in the auto-regulatory loop, we have investigated a series of deletion mutants from the 5
H¯a nking region and the second intron fused to a luciferase reporter gene by co-injection with AP-1 (c-Jun/c-Fos) and c-Jun RNA. Out of seven putative AP-1 target motifs, six of them have been tested and shown to respond to c-Jun (AP-1). Therefore, the activatory effect of AP-1 on BMP-4 transcription can be assigned at the molecular level to accumulated target sites within the 5
H¯a nking region as well as in the second intron which all contribute to BMP-4 gene activation. We also have investigated the ability of c-Jun to interact with these DNA motifs found to be effective in reporter gene activation. In cases of all AP-1 motifs tested we observed a retardation of target sequences by c-Jun protein, albeit at different extent. Finally, we have shown that c-Jun (AP-1) and Xvent-2 act independently. The stimulating effect of both factors on reporter gene activity is additive, inhibition caused by Xvent-2 (P40) is rescued by AP-1 and stimulation of a mutant containing only an AP-1 target site was neither in¯uenced by co-injection with Xvent-2 nor by co-injection with Xvent-2 (P40).
What is the individual contribution of Xvent-2 and AP-1 to BMP-4 gene regulation during the course of embryogenesis? A comparison of the temporal expression patterns of Xvent-2 (Onichtchouk et al., 1996) versus c-Jun (present results) and c-Fos (Kindy and Verma; suggests that Xvent-2 is the major regulatory component for the zygotic activation of BMP-4 gene transcription in vivo. This assumption is based upon the observation that Xvent-2 is directly activated after midblastula transition, whereas zygotic activation of both, c-Fos and c-Jun, is not observed until the early neurula. However, at later stages of development, zygotic transcripts of c-Jun show an extensive degree of spatial overlap to BMP-4 and Xvent-2 transcripts. Thus it is concluded, that c-Jun (AP-1) contributes to the transcriptional activation of the BMP-4 gene, but only at later stages of development.
In summary, we show both for the wild type gene and for promoter/reporter constructs that the Xenopus BMP-4 gene is activated by c-Jun (AP-1). Corresponding target sites are localized in the 5
H¯a nking region and in the second intron. Results obtained from biological and molecular investigations lead to the conclusion that c-Jun (AP-1) is a transcriptional activator of the BMP-4 gene and, since the c-Jun gene is weakly activated by BMP signaling, c-Jun is another potential mediator of the BMP-4 auto-regulatory loop.
Materials and Methods
Whole-mount in situ hybridization
Whole-mount in situs were performed with staged embryos as described (Harland, 1991) with slight modi®ca-tions. Embryos where ®xed in MEMFA after staining, bleached in H 2 O 2 /methanol and documented with a DP10 digital camera (Olympus).
RNA probes were synthesized from various cDNA templates using the DIG labeling kit (Boehringer): BMP-4 cDNA in pSPT18, HindIII linearized, T7 for antisense RNA; Xenopus c-Jun cDNA in pBluescript KS, EcoRI linearized, T7.
Preparation of deletion mutants
The deletion mutants were synthesized as previously described (Metz et al., 1998) by PCR using DNA of phage l XB as template. To facilitate the directed cloning into the luciferase pGL3 basic vector (Promega), the forward primers were 5 H elongated with a restriction site for BamHI (upstream) or KpnI (intron) and all reverse primers with one for HindIII (upstream) or SmaI (intron). Indicated numbers for all mutants refer to nucleotide positions of the BMP-4 gene sequence (EMBL AC: AJ005076).
Preparation of RNAs
RNA used for microinjection experiments was transcribed in vitro with SP6 or T3 polymerase in the presence of GpppG (Cap Scribe Kit, Boehringer) using the following templates: BMP-4 in pSP64T, BamHI linearized, SP6; Xvent-2 in pSP64T, EcoRI linearized, SP6; Xvent-2 (P40) in pRN, PstI linearized, T3; mouse c-Jun in pCS2, NotI linearized, SP6; mouse c-Fos in pCS2, SacII linearized, SP6; Xenopus c-Jun in pCS2, NotI linearized, SP6; Xenopus c-Fos (Kindy and Verma, 1990 ) was isolated by PCR from a stage 28 cDNA library and subcloned into pCS2, NotI linearized, SP6. One ng AP-1 RNA corresponds to 0.5 ng c-Jun plus 0.5 ng c-Fos RNA. Capped RNAs were puri®ed using RNeasy columns (Qiagen).
Embryo injections
5
H promoter deletion and intron-2 fusion constructs were injected at 20 pg/blastomere into two-cell stage embryos in both blastomeres or into four-cell stage embryos in the dorsal blastomeres. When indicated, RNA was co-injected into individual blastomeres. Embryos were collected at stage 12.5 (staging according to Nieuwkoop and Faber, 1975) and frozen in liquid nitrogen.
Luciferase assay
Embryos injected with luciferase reporter constructs were homogenized in 1£ lysis buffer (Promega) using 30 ml buffer/embryo. Samples were left on ice for 10 min followed by a 5 min centrifugation (10 000 rpm) at 48C to pellet debris. Luciferase assays were performed with 90 ml lysate (three embryo equivalents) and with 30 ml luciferase substrate (Promega) using a Lumat LB 9507 luminometer (Berthold). Internal controls for transcriptional activities were performed by using the CMV-pRL vector (cytomegalovirus promoter in front of the Renilla luciferase) and the instructions given by the supplier (Promega).
4.6. Mobility shift assays and DNase I footprinting c-Jun protein was obtained commercially (Promega). For mobility shift assays the desired DNA-fragments were ampli®ed by PCR using a 5 H -labelled primer and an unlabelled reverse primer. Binding reactions for all mobility shift assays were carried out on ice for 25 min in 30 ml binding buffer (25 mM Tris (pH 8.0), 50 mM KCl, 6.25 mM MgCl 2 , 0.5 mM EDTA, 10% glycerol, 0.5 mM DTT, 0.25 mg poly(dI-dC)) and 1 ng of the gel-puri®ed probe.
